AQR Capital Management »

Atara Biotherapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $128k 15k 8.50

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Cigna Corp (CI)
Alphabet Cap Stk Cl C (GOOG)
McKesson Corporation (MCK)
Johnson & Johnson (JNJ)
Broadcom (AVGO)
Ge Aerospace Com New (GE)
Cisco Systems (CSCO)
Eli Lilly & Co. (LLY)
At&t (T)

View all positions for AQR Capital Management

Top funds holding Atara Biotherapeutics

Redmile Group
EcoR1 Capital
Citadel Advisors
Bank of America Corporation
Vanguard Group
Centiva Capital
Acadian Asset Management
Millennium Management
Vestal Point Capital
Qube Research & Technologies
Tang Capital Management
Woodline Partners
BlackRock
Renaissance Technologies
Geode Capital Management

View all funds holding Atara Biotherapeutics